Barclays Maintains Overweight on AbbVie, Raises Price Target to $300
آبفي
AbbVie, Inc. ABBV | 0.00 |
Barclays analyst Emily Field maintains AbbVie (NYSE:
ABBV) with a Overweight and raises the price target from $275 to $300.
Barclays Maintains Overweight on AbbVie, Raises Price Target to $300
AbbVie, Inc. ABBV | 0.00 |